Table 2

Correlation between levels of APM components in transformed plasma cells of MGUS patients at the time of BM sampling and changes in serum M component during the course of 24 months

ComponentPositive cells, %
MESF units
rPrP
δ −0.596 .001 −0.342 .043 
LMP2 −0.321 .021 −0.224 .049 
LMP10 −0.442 .003 −0.381 .045 
TAP1 −0.317 n.s. −0.338 .026 
Calnexin 0.586 .009 0.436 .024 
Calreticulin 0.539 .006 0.399 .028 
Tapasin 0.441 .012 0.340 .039 
β2-m 0.300 n.s. 0.589 .001 
HLA class I 0.233 n.s. 0.463 .006 
ComponentPositive cells, %
MESF units
rPrP
δ −0.596 .001 −0.342 .043 
LMP2 −0.321 .021 −0.224 .049 
LMP10 −0.442 .003 −0.381 .045 
TAP1 −0.317 n.s. −0.338 .026 
Calnexin 0.586 .009 0.436 .024 
Calreticulin 0.539 .006 0.399 .028 
Tapasin 0.441 .012 0.340 .039 
β2-m 0.300 n.s. 0.589 .001 
HLA class I 0.233 n.s. 0.463 .006 

Levels of APM components were expressed as both percentage of cells staining positively and MESF units. Only APM components that had at least 1 significant correlation are shown; Spearman rank test.

β2-m indicates β2-microglobulin; BM, bone marrow; HLA, human leukocyte antigen; and MESF, molecular equivalents of soluble fluorochrome. Other abbreviations as in Table 1.

or Create an Account

Close Modal
Close Modal